DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
VanAssche G. et al.
A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis.
Am J Gastroenterol 2003; 98: 369-376
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.